简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-09-09 19:44 Speed Medical SAE, Secures EGP 1.57 Billion Capital Commitment from Global Emerging Markets (GEM)
2021-09-09 09:49 Pacific Prime Launches the State of Health Insurance Report 2020-2021
2021-09-07 18:05 New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
2021-09-06 19:48 PHC Holdings Corporation: Appointment of Mr. William Donnelly and Mr. Ivan Tornos as Independent External Directors
2021-09-03 18:24 Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use
2021-09-03 15:36 Morinaga Milk Reveals Major Breakthroughs in a ‘Bifidobacteria Training’ Program With Professional Footballer Yuto Nagatomo
2021-09-03 15:24 Patient Safety Movement Foundation Calls for Action in Advance of Second Annual #UniteForSafeCare Event
2021-09-02 19:00 Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
2021-09-02 15:59 AGIC Capital Announces Final Closing of US$1.2 Billion Fund for Investments in Smart Industries
2021-09-02 13:49 Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
2021-08-31 20:44 Jamaica’s Manufacturing Sector to Play Strong Role in Economic Recovery
2021-08-31 15:00 Masimo SafetyNet Alert™ Launches in Western Europe
2021-08-31 13:42 Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines
2021-08-30 18:32 P&G Studios and Harder Than You Think Foster Game Changing Conversations in New Podcast Series “Equal Too: Achieving Disability Equality”
2021-08-30 14:54 Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
2021-08-30 09:43 Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
2021-08-27 12:28 Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
2021-08-26 16:17 RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
2021-08-26 14:01 Noxopharm Phase I Clinical Trial Shows Anti-Inflammatory Response in COVID-19 Patients
2021-08-26 10:58 BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors

Business Wire Weibo

Press Releases

Latest Releases